Fusion Pharmaceuticals Inc (FUSN)
21.54
+0.08
(+0.35%)
USD |
NASDAQ |
May 20, 15:33
Fusion Pharmaceuticals Accounts Payable (Quarterly): 2.503M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.503M |
December 31, 2023 | 1.86M |
September 30, 2023 | 1.057M |
June 30, 2023 | 2.061M |
March 31, 2023 | 1.904M |
December 31, 2022 | 2.686M |
September 30, 2022 | 1.311M |
June 30, 2022 | 1.551M |
March 31, 2022 | 1.774M |
Date | Value |
---|---|
December 31, 2021 | 2.195M |
September 30, 2021 | 3.803M |
June 30, 2021 | 0.685M |
March 31, 2021 | 1.018M |
December 31, 2020 | 3.399M |
September 30, 2020 | 0.956M |
June 30, 2020 | 0.703M |
March 31, 2020 | 2.89M |
December 31, 2019 | 0.83M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.685M
Minimum
Jun 2021
3.803M
Maximum
Sep 2021
1.844M
Average
1.817M
Median
Accounts Payable (Quarterly) Benchmarks
AstraZeneca PLC | 19.70B |
Landos Biopharma Inc | 1.565M |
Perspective Therapeutics Inc | 6.027M |
Acasti Pharma Inc | 0.913M |
Aurinia Pharmaceuticals Inc | 4.327M |